Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
12 studies found for:    HUPERZINE A
Show Display Options
RSS Create an RSS feed from your search for:
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia
Conditions: Schizophrenia;   Dementia
Intervention: Drug: Huperzine A
2 Unknown  Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A
Conditions: Healthy;   Bioavailability
Intervention: Drug: Huperzine A
3 Recruiting Effects of Huperzine A in Treatment of Moderate to Severe TBI
Condition: Traumatic Brain Injury
Interventions: Drug: Huperzine A;   Drug: Placebo
4 Completed Huperzine A in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: Huperzine A
5 Unknown  Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Huperzine A;   Drug: huperzine A;   Drug: Placebo
6 Not yet recruiting Effects of Hearing Rehabilitative Interventions and Huperzine A on Presbycusis(Δ,kHz, dB,MMSE, AD)
Conditions: Presbycusis;   Tinnitus;   Cognitive Impairment
Interventions: Device: digital hearing aids,;   Drug: Huperzine A;   Other: digital hearing aids and Huperzine A;   Other: placebo
7 Completed Rivastigmine and Huperzine A as Treatments for Cocaine Dependence
Conditions: Cocaine Dependence;   Cocaine Addiction;   Cocaine Abuse;   Substance Abuse
Interventions: Drug: Placebo;   Drug: Rivastigmine 3 mg;   Drug: Huperzine A 0.4 mg;   Drug: Rivastigmine 6 mg;   Drug: Huperzine A 0.8 mg
8 Completed Huperzine for Cognitive and Functional Impairment in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: placebo;   Drug: huperzine 0.2 mg BID;   Drug: huperzine 0.4 mg BID;   Drug: huperzine 0.8 mg BID
9 Not yet recruiting Early Diagnosis and Early Treatment of Alzheimer's Disease Based on Senile Plaque Imaging
Conditions: Mild Cognitive Impairment;   Biomarker;   Diagnosis;   Treatment
Interventions: Drug: Huperzine A;   Drug: Placebo
10 Recruiting Bioavailability, Safety, and Tolerability of BIS-001 ER
Condition: Epilepsy, Complex Partial
Intervention: Drug: BIS-001 ER
11 Completed Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance
Condition: Biomarkers, Pharmacological
Interventions: Drug: Huperzine A;   Drug: Donepezil;   Drug: Galantamine;   Other: Placebo
12 Completed Single Photon Emission Computed Tomography (SPECT) Imaging Study of Professional American Football Players
Condition: Traumatic Brain Injury
Intervention: Dietary Supplement: Multivitamin Supplement intervention

Study has passed its completion date and status has not been verified in more than two years.